Breast MRI pp 221-236 | Cite as

New Developments in Breast Magnetic Resonance Imaging


This chapter describes some of the new developments in breast MRI including higher field systems, dedicated breast MRI systems, and imaging and spectroscopic techniques that attempt to improve the specificity (and possibly sensitivity) of breast MRI. Those include diffusion-weighted breast imaging, perfusion imaging, hydrogen spectroscopy and spectroscopic imaging.


Apparent Diffusion Coefficient Breast Lesion Breast Magnetic Resonance Image Breast Coil Total Choline 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hoult DL, Richards RE. The signal-to-noise ratio of the nuclear magnetic resonance experiment. J. Magn. Res. 1976; 24: 71–85.Google Scholar
  2. 2.
    Edelstein WA, Glover GH, Hardy CJ, Redington RW. (1986) The intrinsic signal-to-noise ratio in NMR imaging. Magn. Reson. Med. 3: 604–618.PubMedCrossRefGoogle Scholar
  3. 3.
    Haacke EM, Brown RW, Thompson MR, Magnetic Resonance Imaging: Physical Principles and Sequence Design. New York: John Wiley & Sons, 1999, especially Ch. 15, 331–380.Google Scholar
  4. 4.
    Kuhl CK, Jost P, Morakkabati N, et al. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: Initial Experience. Radiology 2006 239: 666–676.PubMedCrossRefGoogle Scholar
  5. 5.
    Daniel BL, Yen YF, Glover GH, Breast disease: dynamic spiral MR imaging Radiology 1998; 209: 499.Google Scholar
  6. 6.
    Harms SE, Flamig DP, Hensley KL, et al. MR imaging of the breast with rotating delivery of excitation off-resonance: clinical experience with pathologic correlation. Radiology 1993; 187: 493–501.PubMedGoogle Scholar
  7. 7.
    Causer PA, Piron CA, Jong RA, et al. MR imaging-guided breast localization system with medial or lateral access. Radiology 2006; 240: 369–379.PubMedCrossRefGoogle Scholar
  8. 8.
    Le Bihan D, Diffusion MR imaging: clinical application. Am. J. Roentgenol. 1992; 159: 591–599.Google Scholar
  9. 9.
    Sinha S, Sinha U. Functional magnetic resonance of human breast tumors: diffusion and perfusion imaging. Annals New York Academy of Sciences 95–115.Google Scholar
  10. 10.
    Bradley WG, Chen D-Y, Atkinson J, Edelman RE. Fast spin-echo and echo-planar imaging. In DD Stark and WG Bradley, eds. Magnetic Resonance Imaging, 3rd Edition.St. Louis: C.V. Mosby Publishing Co., 1999; 125–157.Google Scholar
  11. 11.
    Sinah S, Lucas-Quesada FA, Sinha U, In-vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J. Magn. Reson. Imaging 2002; 15: 693–704.CrossRefGoogle Scholar
  12. 12.
    Detre JA Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed. 1994; 7: 75–82.PubMedCrossRefGoogle Scholar
  13. 13.
    Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J. Magn. Reson. Imaging 1997; 7: 91–101.PubMedCrossRefGoogle Scholar
  14. 14.
    Roberts HC, Roberts TPL, Brasch RC, et al. Quantitative measurement of microvacular permeability in human brain tumors achieved using dynamic contrast enhanced MR imaging: correlation with histologic grade. Am. J. Neuroradiol. 2000; 21: 891–899.PubMedGoogle Scholar
  15. 15.
    Kuhl CK, Bieling H, Gieseke J, et al. Breast neoplasms: T2* susceptibility-contrast. First-pass perfusion MR imaging. Radiology 1997; 202: 87–95.PubMedGoogle Scholar
  16. 16.
    Helbich T, Roberts TPL, Grossman A, et al. MR imaging of breast tumors: testing of different analytic methods with gadopentetate (abstract). Eur. Radiol. 1999; 9 (suppl 1): 410.Google Scholar
  17. 17.
    Kvistad KA. Breast lesions: evaluation with dynamic contrast enhanced T1-weighted MR imaging and with T2*-weighted first pass perfusion imaging. Radiology 2000; 216: 545–553.PubMedGoogle Scholar
  18. 18.
    DeLille J, PJ Slanetz, ED Yeh, et al. Breast cancer: regional blood flow and blood volume measured with magnetic susceptibility-based MR imaging – initial results. Radiology 2002; 223: 558–565.PubMedCrossRefGoogle Scholar
  19. 19.
    Gribbestad IS, Petersen SB, FJosne HE, et al. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed. 1994; 7: 181–194.PubMedCrossRefGoogle Scholar
  20. 20.
    Nagandank W. Studies of human tumors by MRS. A review. NMR Biomed 1992; 5: 303–324.Google Scholar
  21. 21.
    Podo F. Tumour phospholipids metabolism. NMR Biomed. 1999; 12: 413–439.PubMedCrossRefGoogle Scholar
  22. 22.
    Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipids metabolism of human mammary epithelial cells. Cancer Research 1999; 59: 80–84.PubMedGoogle Scholar
  23. 23.
    Ackerstaff E, Glunde K, Bhujwalla ZM. Choline phospholipids metabolism: a target in cancer cells? Journal of Cellular Biochemistry 2003; 90: 525–533.PubMedCrossRefGoogle Scholar
  24. 24.
    Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998; 209: 269–275.PubMedGoogle Scholar
  25. 25.
    Gribbestad IS, Singstad TE, Nilsen G, et al. In vivo H-1 MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998; 8: 1191–1197.PubMedCrossRefGoogle Scholar
  26. 26.
    Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo (1) H MR spectroscopy. J Magn Reson Imaging 1999; 10: 159–164.PubMedCrossRefGoogle Scholar
  27. 27.
    Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy – initial results. Radiology 2001; 220: 40–46.PubMedGoogle Scholar
  28. 28.
    Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001; 84: 1016–1022.PubMedCrossRefGoogle Scholar
  29. 29.
    Thomas MA, Binesh N, Yue K, DeBruhl N. Volume-localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer. J Magn Reson Imaging 2001; 14: 181–186.PubMedCrossRefGoogle Scholar
  30. 30.
    Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001; 68: 45–54.PubMedCrossRefGoogle Scholar
  31. 31.
    Katz-Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J. Natl. Cancer Inst. 2002; 94: 1197–1203.PubMedGoogle Scholar
  32. 32.
    Bolan PJ, DelaBarre L, Baker EH, et al. “Eliminating spurious lipid sidebands in 1H MRS of breast lesions”. Magn Reson Med 2002; 48(2): 215–222.PubMedCrossRefGoogle Scholar
  33. 33.
    Bolan PJ, Meisamy S, Baker EH, et al. “In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.” Magn Reson Med 2003; 50(6): 1134–1143.PubMedCrossRefGoogle Scholar
  34. 34.
    Star-Lack, J. M., E. Adalsteinsson, et al. “In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements.” Am J Neuroradiol 2000; 21(1): 183–93.PubMedGoogle Scholar
  35. 35.
    Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 1999; 19: 1737–1746.PubMedGoogle Scholar
  36. 36.
    Bartella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 2006; 239: 686–692.PubMedCrossRefGoogle Scholar
  37. 37.
    Huang W, Fisher PR, Khaldoon D, et al. Detection of malignancy: diagnostic MR protocol for improved specificity. Radiology 2004; 232: 585–591.PubMedCrossRefGoogle Scholar
  38. 38.
    Yeung DK, Cheung HS, Tse GM. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 2002; 225: 190–197.PubMedCrossRefGoogle Scholar
  39. 39.
    Meisamy S, Bolan PJ, Baker EH, et al. Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology 2005; 236: 465–475.PubMedCrossRefGoogle Scholar
  40. 40.
    Meisamy S, Bolan PJ, Baker EH, et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in Vivo 1H MR spectroscopy—a pilot study at 4 T. Radiology 2004; 233: 424–431.PubMedCrossRefGoogle Scholar
  41. 41.
    Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205–216.PubMedCrossRefGoogle Scholar
  42. 42.
    Jacobs MA, Barker PB, Bottomley PA, Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. Journal of Magnetic Resonance Imaging 2004; 19: 68–75.PubMedCrossRefGoogle Scholar
  43. 43.
    Medved M, Newstead GM, Abe H, et al. High spectral and spatial resolution MRI of breast lesions: preliminary clinical experience. Am. J. Roentgenol. 2006; 186: 30–37 and references therein.CrossRefGoogle Scholar
  44. 44.
    Kuhl CK, Kooijman H, Gieseke J, Schildtt H. Effect of B1 in homogeneity on breast MR imaging at 3.0 T. (Letters to the Editors) Radiology 2007; 244: 929–930.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Personalised recommendations